Eczema, or atopic dermatitis, often worsens during seasonal changes like monsoon and autumn. Fluctuating humidity, allergens, ...

Apollo Therapeutics’ $15 million bet on Avalo’s anti-IL-18 monoclonal antibody appears to have paid off after the candidate ...

Sanofi stock plummeted Thursday after the company's experimental eczema drug proved meaningfully inferior to Dupixent.

First FDA-approved medication for atopic dermatitis (eczema), plaque psoriasis, and seborrheic dermatitis to win prominent “Breakthrough ...

Amlitelimab showed efficacy in skin clearance and disease severity compared to placebo in a phase 3 study with adolescent and ...

Eczema affects 1 in 5 infants and can lead to allergies and asthma later. Dr. Elisa Song, chief medical officer at Tiny Health, explains study on how parents can help prevent baby eczema.

Data from the late-stage trial of amlitelimab weren’t as strong as the results seen in Phase 2, adding to doubts about a drug ...

Doctors have shared their top tips for travelling with eczema, offering some wise words for people who find heading to ...

Sanofi (SNY) stock drops after Phase 3 trial results for amlitelimab, its experimental therapy for eczema, disappointed ...

World Atopic Eczema Day 2025 calls for early intervention, better care and greater awareness of the hidden toll of atopic ...

World Atopic Eczema Day 2025 calls for early intervention, better care, and greater awareness of the hidden toll of atopic ...

Sanofi (NASDAQ:SNY) stock took a beating Thursday after its latest eczema drug trial left Wall Street unconvinced, even ...